. Author manuscript; available in PMC: 2022 Sep 6.

Published in final edited form as: Eur J Gastroenterol Hepatol. 2021 Apr 1;33(4):583–588. doi: 10.1097/MEG.0000000000002057

Table 4:

Mortality rate comparison according to HIV status

_{HIV status}╲^Mortality	Frequency (%)	Crude Rate Ratio (95% CI)	Minimally adjusted^* Rate Ratio (95% CI)	Model 1^**	Model 2^***
HIV (–) (Baseline)	180 (74.3%)	RR = 1.36 (0.81 – 2.27) P = 0.23	RR = 1.61 (0.93 – 2.77) P = 0.08	RR = 1.95 (1.11 – 3.41) P = 0.01	RR = 1.96 (1.12 – 3.44) P = 0.01
HIV (+)	23 (92.0%)	RR = 1.36 (0.81 – 2.27) P = 0.23	RR = 1.61 (0.93 – 2.77) P = 0.08	RR = 1.95 (1.11 – 3.41) P = 0.01	RR = 1.96 (1.12 – 3.44) P = 0.01

Note:

Minimally adjusted: Age and sex

^**

Model 1: Adjusted for age, sex, BCLC, symptoms, Child-Pugh, treatment and AFP

^***

Model 2: Adjusted for age, sex, BCLC, symptoms, Child-Pugh, AFP, number of lesions, intravascular metastasis, extravascular metastasis, size of the bigger lesion and treatment.